Literature DB >> 31827016

Structure and function of the insulin receptor-a personal perspective.

Masato Kasuga1.   

Abstract

Immunoprecipitation with autoantibodies to the insulin receptor derived from patients with extreme insulin resistance and acanthosis nigricans revealed that the receptor is comprised of two subunits of 135 kDa (α subunit) and 95 kDa (β subunit) and that insulin induces the rapid phosphorylation of the β subunit in intact cells. Incubation of a highly purified insulin receptor preparation with [γ-32P]ATP also resulted in tyrosine phosphorylation of the β subunit in an insulin-dependent manner, suggesting that the receptor itself is a tyrosine-specific protein kinase. Furthermore, a Japanese boy with insulin resistance and acanthosis nigricans was found to be heterozygous for a mutation of the insulin receptor gene that resulted in the replacement of glycine-996 with valine in the ATP binding site of the receptor. Expression of the mutant receptor in cultured cells revealed it to be deficient in tyrosine kinase activity and mediation of insulin action, suggesting that the tyrosine kinase activity of the insulin receptor is essential for insulin action in vivo.

Entities:  

Keywords:  gene mutation; phosphotyrosine; protein kinase

Mesh:

Substances:

Year:  2019        PMID: 31827016      PMCID: PMC6920081          DOI: 10.2183/pjab.95.039

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  38 in total

1.  Putative mediators of insulin action: regulation of pyruvate dehydrogenase and adenylate cyclase activities.

Authors:  A R Saltiel; M I Siegel; S Jacobs; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

2.  Transforming gene product of Rous sarcoma virus phosphorylates tyrosine.

Authors:  T Hunter; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

3.  Evidence that insulin activates an intrinsic plasma membrane protease in generating a secondary chemical mediator.

Authors:  J R Seals; M P Czech
Journal:  J Biol Chem       Date:  1980-07-25       Impact factor: 5.157

4.  Autoantibodies against the insulin receptor recognize the insulin binding subunits of an oligomeric receptor.

Authors:  M Kasuga; E van Obberghen; K M Yamada; L C Harrison
Journal:  Diabetes       Date:  1981-04       Impact factor: 9.461

5.  Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance.

Authors:  J S Flier; C R Kahn; J Roth; R S Bar
Journal:  Science       Date:  1975-10-03       Impact factor: 47.728

6.  Photoaffinity labeling of insulin receptor proteins of liver plasma membrane preparations.

Authors:  C C Yip; C W Yeung; M L Moule
Journal:  Biochemistry       Date:  1980-01-08       Impact factor: 3.162

7.  The structure of insulin receptor and its subunits. Evidence for multiple nonreduced forms and a 210,000 possible proreceptor.

Authors:  M Kasuga; J A Hedo; K M Yamada; C R Kahn
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

8.  Tyrosine-specific protein kinase activity is associated with the purified insulin receptor.

Authors:  M Kasuga; Y Fujita-Yamaguchi; D L Blithe; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

9.  Insulin--receptor interactions in adipose tissue cells: direct measurement and properties.

Authors:  P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

10.  Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor.

Authors:  M Kasuga; F A Karlsson; C R Kahn
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

View more
  2 in total

Review 1.  SX-fraction: Promise for novel treatment of type 2 diabetes.

Authors:  Sensuke Konno
Journal:  World J Diabetes       Date:  2020-12-15

Review 2.  Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments.

Authors:  Mina Wang; Yan Tan; Yifan Shi; Xu Wang; Zehuan Liao; Peng Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-25       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.